Other Species / Isoforms
  PTGIR (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S14-p
NLTYVRGsVGPAtsT
0 1
PTGIR (human) NLTYVRGsVGPAtsT S14-p
PTGIR (mouse) NITYVQDSVGPATST S42
PTGIR (rat) NITYVQDSVGPATST S43
T19-p
RGsVGPAtsTLMFVA
0 1
PTGIR (human) RGsVGPAtsTLMFVA T19-p
PTGIR (mouse) QDSVGPATSTLMFVA T47
PTGIR (rat) QDSVGPATSTLMFVA T48
S20-p
GsVGPAtsTLMFVAG
0 1
PTGIR (human) GsVGPAtsTLMFVAG S20-p
PTGIR (mouse) DSVGPATSTLMFVAG S48
PTGIR (rat) DSVGPATSTLMFVAG S49
S328-p
TPLSQLAsGRRDPRA
Upstream
Downstream
3 0
Effects on Modified Protein
  • receptor desensitization, altered
Kinase, in vitro:
  • PKCA (rat)
Putative in vivo kinases:
  • PKCA (human)
  • PKCA (rat)
Treatment
  • cicaprost
  • GF109203X
  • H-89
  • iloprost
  • phorbol_ester
view more >
PTGIR (human) TPLSQLAsGRRDPRA S328-p
PTGIR (mouse) APLSRPAsGRRDPPA S355-p
PTGIR (rat) TPLSRPVSGRRDTLA S356
S337-p
RRDPRAPsAPVGKEG
0 1
PTGIR (human) RRDPRAPsAPVGKEG S337-p
PTGIR (mouse) RRDPPAPTSLQAKEG T364
PTGIR (rat) RRDTLAPDsLQAKEG D365
A338
RDPRAPsAPVGKEGS
0 1
PTGIR (human) RDPRAPsAPVGKEGS A338
PTGIR (mouse) RDPPAPTSLQAKEGS S365
PTGIR (rat) RDTLAPDsLQAKEGN S366-p